1 | Bosentan (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
2 | Bosentan (Tracleer) (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬 |
3 | Bosentan 125 mg (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬 |
4 | Bosentan 62.5 mg (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬 |
5 | Bosentan administration (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
6 | Bosentan and Sildenafil (D01227) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
(D01227),
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
7 | Bosentan group (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬 |
8 | BOSENTAN MONOHIDRATO (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
9 | Bosentan monohydrat (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
10 | BOSENTAN MONOHYDRATE (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 84, 86, 88 💬 |
11 | BOSENTAN MYLAN (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 41 41 💬 |
12 | Bosentan, Ambrisentan (D01227) | [2] Ambrisentan Ambrisentan, Bosentan | [3] Bosentan
Bosentan
(D01227),
Ambrisentan
,
Bosentan
💬 | [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
13 | Duo-Therapy with Sildenafil + Bosentan (D01227) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
(D01227),
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
14 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (D01227) | [4] Bosentan Bosentan, Macitentan, Sildenafil, Tadalafil | [5] Bosentan
Bosentan
(D01227),
Tadalafil
,
Bosentan
,
Sildenafil
,
Macitentan
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
15 | Sildenafil 20mg and Bosentan 62.5mg (D01227) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
(D01227),
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬 |
16 | Sildenafil singly or in association with Bosentan (D01227) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
(D01227),
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |